By Hammad Irshad, Research Scientist As drug development expands into increasingly complex therapeutic modalities, delivery strategy has become a critical factor in development success. For many programs, inhalation is still treated as a formulation challenge to address later in development. Yet for inhaled products, success depends on much more than the therapeutic itself. Formulation, aerosolization, deposition, device selection, and dose ... Read More The post The Inhalation Gap: Why Early Delivery Strategy Matters More Than Most Drug Developers Think appeared first on Lovelace Biomedical .